指南与共识消化道肿瘤与早癌消化内镜

45-49岁与更年长人群筛查结肠镜的腺瘤及无蒂锯齿状病变检出率:新结直肠癌筛查指南引入后的分析

Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines.
指南 / 共识 · Clin Gastroenterol Hepatol · 2022-05-14

在美国某医疗系统比较新指南前后筛查结肠镜 volumes 与病变检出率:45-49岁首次筛查比例从3.5%升至11.6%(相对风险3.36,95%CI 2.45-4.61)。第二期45-49岁腺瘤检出率34.3%等与50-54岁首次筛查及60-64岁再筛查相近;总体腺瘤检出率从35.1%升至42.6%(P<.0001)。

要点

  • 45-49岁首次筛查结肠镜比例从3.5%升至11.6%,相对风险3.36(95%CI 2.45-4.61)。
  • 第二期45-49岁腺瘤检出率34.3%,与50-54岁首次筛查38.2%、60-64岁再筛查33.4%相近。
  • 总体腺瘤检出率从35.1%升至42.6%(P<.0001),45-49岁各组检出率无下降。

核心结论

  • 在本医疗系统中,降低结直肠癌筛查起始年龄对结肠镜量的年龄分布影响温和,未损害筛查产出。
  • 45-49岁平均风险人群的病变检出率(包括进展期腺瘤)接近50-54岁首次筛查和60-64岁再筛查的水平。
  • 需要全国性监测以全面评估降低结直肠癌筛查起始年龄的影响。

研究设计与样本

  • 比较本医疗系统内第一期(2017年10月至2018年12月,首次指南变更前)与第二期(2019年1月至2021年8月,新指南时代)的结肠镜量和病变检出率。

主要发现

  • 45-49岁首次筛查结肠镜比例从3.5%升至11.6%(相对风险3.36;95%CI 2.45-4.61)。
  • 第二期45-49岁首次筛查的腺瘤、进展期腺瘤、无蒂锯齿状病变、进展期无蒂锯齿状病变检出率及每结肠镜腺瘤数、每结肠镜病变数分别为34.3%、6.3%、8.6%、2.9%、0.58、0.69。
  • 第二期50-54岁首次筛查的相应指标分别为38.2%、5.8%、9.4%、3.0%、0.63、0.76;60-64岁再筛查分别为33.4%、6.1%、7.2%、2.3%、0.61、0.70。
  • 从第一期到第二期,所有检出率、每结肠镜腺瘤数和每结肠镜病变数均增加(如总体腺瘤检出率35.1% vs 42.6%;P<.0001),45-49岁人群无任何下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: All major U.S. guidelines now endorse average-risk colorectal cancer (CRC) screening at 45-49 years of age. Concerns exist that endoscopic capacity may be strained, that low-risk persons may self-select for screening, and that calculations of the adenoma detection rate may be diluted. We analyzed age-specific screening colonoscopy volumes and lesion detection rates before vs after the endorsement of CRC screening at 45-49 years of age. METHODS: We compared colonoscopy volumes and lesion detection rates in our healthcare system during period 1 (October 2017 to December 2018), before the first change in guidelines, vs period 2 (January 2019 to August 2021), the era of new guidelines. RESULTS: The proportion of first-time screening colonoscopies performed in 45- to 49-year-olds increased from 3.5% to 11.6% (relative risk, 3.36; 95% CI, 2.45-4.61). The period 2 detection rates for adenoma, advanced adenoma, sessile serrated lesion, advanced sessile serrated lesion, adenomas per colonoscopy, and lesions per colonoscopy were very similar for 45- to 49-year-olds (34.3%, 6.3%, 8.6%, 2.9%, 0.58, and 0.69, respectively) and 50- to 54-year-olds (38.2%, 5.8%, 9.4%, 3.0%, 0.63, and 0.76, respectively) at first-time screening, and for 60- to 64-year-olds at rescreening (33.4%, 6.1%, 7.2%, 2.3%, 0.61, and 0.70, respectively). All detection rates, adenomas per colonoscopy, and lesions per colonoscopy increased from period 1 to period 2 (eg, overall adenoma detection rate 35.1% vs 42.6%; P < .0001), without any decreases among 45- to 49-year-olds. CONCLUSIONS: In our healthcare system, a lower CRC screening initiation age has modestly affected colonoscopy volume by age without compromising screening yield. Lesion detection rates, including for advanced adenomas, in average-risk 45- to 49-year-olds approximate those in 50- to 54-year-olds at first-time screening and 60- to 64-year-olds at rescreening. National monitoring is needed to assess fully the impact of lowering the CRC screening initiation age.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Ladabaum U, Shepard J, Mannalithara A, et al. Adenoma and Sessile Serrated Lesion Detection Rates at Screening Colonoscopy for Ages 45-49 Years vs Older Ages Since the Introduction of New Colorectal Cancer Screening Guidelines. Clin Gastroenterol Hepatol. 2022. PMID: 35580769. doi:10.1016/j.cgh.2022.04.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。